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A B S T R A C T
Among three commonly used strains of laboratory rats, Wistar rats perform more neurological tasks better then Lewis
and Sprague-Dawley (SD) rats. Liver is the main site of insulin-like growth factor (IGF) production and pancreas is the
exclusive site of insulin production. Insulin stimulates neuronal development and appropriate IGF-I input is critical in
brain growth. Glycosphingolipids (GSLs) are important mediators of insulin secretion and action. Therefore, this study
investigated GSL phenotypes of liver and pancreas with hypothesis that they are different in three rat strains. Total GSL
fractions (neutral and gangliosides) were analysed by high performance thin-layer chromatography (HPTLC). Complex
gangliosides were detected by HPTLC immunostaining using cholera toxin B subunit after neuraminidase pretreat-
ment. Wistar rats had the highest liver weight/body weight ratio and SD rats had the highest pancreas weight/body
weight ratio. Ganglioside GM3 was more expressed in the liver of Wistar compared to Lewis and SD rats. SD rats con-
tained scarce quantities of GD1a and b-series gangliosides in the liver compared to Wistar and Lewis rats. Pancreatic
b-series ganglioside content was also the lowest in SD rats. This study represents differences in the hepatic and pancre-
atic ganglioside phenotypes of three rat strains that could influence IGF and insulin secretion and action.
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Introduction
Morphologic, sensory and motor differences exist be-
tween the Wistar, Lewis, and Sprague-Dawley (SD) rats1.
Wistar rats have enhanced biosynthesis of triacylglycerol
from naturally occurred cis fatty acids compared to SD
rats2. When rats fast for 2 days, ketogenesis from cis
fatty acids is slower in Wistar compared to SD strain2.
The stimulation index of Lewis pancreatic islets after
glucose challenge is almost three times as high as that of
Wistar islets3. Liver is the main site of insulin-like growth
factor (IGF) synthesis although it could be produced lo-
cally by most cell types4. IGF play a particular role in the
trophic maintenance of neurons involved in the coordi-
nation of sensorimotor function in the cerebellum5. Pan-
creas is the exclusive site of insulin production, and the
role of insulin during development, although not well de-
fined yet, may be related to the control of neuronal
survival6. Sialic acid-containing glycosphingolipids, gan-
gliosides, are known to modulate the activity of a number
of receptor tyrosine kinases, including the insulin recep-
tor7. Inhibition of glycosphingolipid synthesis can signifi-
cantly improve insulin sensitivity and glucose homeo-
stasis8. The tyrosine kinase activity of the epidermal
growth factor receptor can be enhanced or repressed by
gangliosides GD1a or GM3, respectively9,10. Therefore,
our hypothesis was that Wistar, Lewis, and SD rats dif-
fered in their hepatic and pancreatic glycosphingolipid
phenotypes. In this study, we examined expression of two
GSL subclasses: ceramide monohexosides and ganglio-
sides in the liver and pancreas of one month old Wistar,
Lewis and SD rats.
Materials and Methods
Animals
Experiments were performed on one month old male
Wistar (weighting 94.2±8.9 g, mean±standard deviation),
Lewis (85.4±14.3) and Sprague-Dawley rats (71.9±8.5)
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(n=10, for each rat strain). All rats were raised under
controlled conditions (temperature, 22±1oC; light sched-
ule: 14h of light and 10h of dark) at University of Split
Animal Facility. Laboratory food and tap water were sup-
plied ad libitum. Animals were bred and maintained ac-
cording to the NIH Guide for the Use and Care of Labora-
tory Animals and the University Medical School Ethics
Committee has approved the experimental protocol. For
GSL analysis, rats were sacrificed with prolonged anes-
thesia (diethyl ether); the tissues were dissected out and
stored at –20°C until GSL extraction.
Isolation of GSLs from tissues
Liver and pancreas were dissected from 10 animals of
each group. Identical tissues were pooled, minced with a
scalpel, suspended in distilled water in a 1/2 ratio (w/v),
homogenized and isolated according to standard proce-
dures11. Briefly, GSLs were extracted with chloroform/
methanol (2/1, v/v), chloroform/methanol (1/1, v/v) and
chloroform/methanol (1/2, v/v) (10-fold volumes of the
tissue wet weight) for 30 min with sonication. The com-
bined extracts were dried and phospholipids were sapo-
nified with aqueous 1 M NaOH for 1 h at 37°C. After neu-
tralization with 1 M HCl, the samples were dialyzed
against deionized water and dried12. The extracts were
adjusted to defined volumes of chloroform/methanol (2/1,
v/v) corresponding to 2 mg wet tissue weight/mL for all
tissues.
High performance thin layer chromatography
The gangliosides were separated on silica gel 60 pre-
-coated high performance thin layer chromatography
plates (HPLTC-plates, size 10x10cm, and thickness 0.2
mm, Merck, Darmstadt, Germany) in the solvent chloro-
form/methanol/water (120/70/17, each by vol., with 2 mM
CaCl2) and visualized with orcinol12. Orcinol staining
was performed three times, with identical results.
Detection of GM1a-type gangliosides by HPTLC
immunostaining
The HPTLC binding assay using cholera toxin B sub-
unit (= choleragenoid) for specific detection of GM1 was
developed by Magnani et al.13 and was used with modi-
fications14,15. A fixed silica gel plate with polyisobutylme-
thacrylate was overlayed with 250 ng/mL choleragenoid
(Sigma, Deisenhofen, Germany), diluted in solution A
(phosphate-buffered saline, PBS, supplemented with 1%
bovine serum albumin and 0.02% NaN3) for 2 h at room
temperature. Unbound choleragenoid was removed by
washing of plates five times with solution B (0.05%
Tween 21, 0.02% NaN3 in PBS) followed by rabbit anti-
-choleragenoid and secondary goat anti-rabbit IgG anti-
body incubation, both diluted 1:2000 (both from Abcam
Cambrige, UK). After 1 h of incubation with secondary
antibody, the plates were washed again, followed by two
rinses with glycine buffer (0.1M glycine, 1mM ZnCl2,
1mM MgCl2, pH 10.4), to remove phosphate. Bound
choleragenoid was visualized with 0.05% (w/v) 5-bro-
mo-4-chloro-3-indolylphosphate (Biomol, Hamburg, Ger-
many) in glycine buffer. To reveal the presence of GD1a,
GD1b, GT1b, and GQ1b the plates were incubated with 5
mU/mL V. cholerae neuraminidase (Sigma, Deisenhofen,
Germany) (2 h, 37°C) prior to combined choleragenoid
immunostaining14. Choleragenoid immunostaining with
neuraminidase pretreatment was performed three times,
with identical results.
Estimation of relative quantities of ganglioside frac-
tions was performed by AutoCAD software (Autodesk,
GmbH, Germany).
Statistical analysis
Data of body weight and the organ weight/ body
weight ratio are given as means±standard deviations. Re-
peated measures ANOVA with Tukey-Kramer post-hoc
test were performed using GraphPad Prism version 4.00
for Windows (San Diego, USA).
These tests were chosen due to the small number
(n=10) of the samples in the each group.
Results
Liver weight/body weight ratio was significantly hi-
gher in Wistar compared to other two strains (p<0.05,
Table 1). There was no difference between Lewis and SD
liver weight/body weight ratio. Pancreas weight/body
weight ratio was significantly higher in SD compared to
other two strains (p<0.05). There was no difference be-
tween Wistar and Lewis pancreas weight/body weight ra-
tio. Staining of HPTL-chromatograms with orcinol re-
vealed that major neutral glycosphingolipids in the liver
of all strains were two ceramide monohexoside fractions
and one GSL band chromatographed at the position of
Gb4Cer (Figure 1). Ganglioside GM3 was present only in
traces, not detectable by densitometric software, in Lewis
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TABLE 1




Liver weight/body weight (g/g) *,**0.0521±0.0029 **0.0407±0.0025 *0.0412±0.0044 36.32 <0.0001
Pancreas weight/body weight (g/g) ***0.0033±0.0004 ****0.0035±0.0005 ***,****0.0042±0.0006 6.484 <0.05
Data are reported as means±standard deviations for 10 samples in each group. Tukey’s Multiple Comparison test
*p<0.05 W vs SD; **p<0.05 W vs L; ***p<0.05 W vs SD; ****p<0.05 L vs SD
and SD liver, while proportion of GM3 in total GSL con-
tent was 14% in the Wistar liver (1051/sum of all GSL
fractions, Figure 2). Low level of GM3 detection in Lewis
and SD liver was due to low quantity of hepatic GSL ex-
tracts applied (corresponding to 30 mg liver wet weight).
Choleragenoid stain of hepatic and pancreatic ganlio-
sides is shown at Figure 3. Cholera toxin B subunit pref-
erentially reacts with GM1 and after neuraminidase treat-
ment also with gangliosides derived from gangliotetraose.
As the reaction does not have to run quantitatively, col-
our response of individual gangliosides can be rather dif-
ferent. It is possible to compare quantitative changes of
each individual ganglioside but not proportions among
them. Lower GD1a ganglioside fraction was 6 fold and 4
fold higher expressed in Wistar and Lewis liver, respec-
tively, compared to SD liver (Figure 3 and Figure 4). The
results on densitometric analysis of ganglioside detected
with choleragenoid are given in graphical form only for
the fractions that were different more then 2 fold be-
tween the strains (Figure 4 and Figure 5). The separa-
tion of individual rat gangliosides on HPTLC plates as
double bands is common feature, due to the variation in
the ceramide portion (C16- or C-24 fatty acids). The up-
per band is composed mainly of C-24 fatty acid, and the
lower band of C-16 fatty acid15. Ganglioside GD1b was 4
fold higher expressed in Wistar liver compared to SD
liver (Figures 3 and 4). The difference in b-series gan-
glioside expression was more obvious in pancreas. Wistar
pancreas showed 5 fold higher amount of both GD1b and
GT1b ganglioside compared to SD pancreas. Lewis strain
contained higher pancreatic GD1b, being 6 fold increased
compared to SD rats (Figures 3 and 5).
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Fig. 1. Orcinol stain of HPTLC-separated GSL fractions from
liver and pancreas of Wistar (W), Lewis (L) and Sprague-Dawley
(SD) rats. GSL amounts corresponding to 30 mg liver and pan-
creas wet weight were chromatographed together with reference
GSLs, S1 and S2. S1: 5 mg of gangliosides from rat brain, S2: 10
mg of neutral GSLs from mouse brain, and S3: 5 mg of neutral







































Fig. 2. Areas under densitometric peaks of distinct hepatic gan-
glioside fractions in Wistar (W), Lewis (L) and Sprague-Dawley
(SD) rats determined with orcinol staining.
Fig. 3. Immunostain with choleragenoid after V. cholerae neura-
minidase treatment of HPTLC-separated ganglioside fractions
from liver and pancreas of Wistar (W), Lewis (L) and Sprague-
-Dawley (SD) rats. Ganglioside amounts corresponding to 5 mg
liver and pancreas wet weight were chromatographed together









































Fig. 4. Areas under densitometric peaks of distinct hepatic gan-
glioside fractions in Wistar (W), Lewis (L) and Sprague-Dawley




































Fig. 5. Areas under densitometric peaks of distinct pancreatic gan-
glioside fractions in Wistar (W), Lewis (L) and Sprague-Dawley
(SD) rats determined with choleragenoid.
Discussion
This study showed some differences in hepatic and
pancreatic ganglioside phenotypes in Wistar, Lewis, and
SD rats. Rat hepatic gangliosides are well described by
Kasai et al.16 and pancreatic gangliosides by Dotta et
al.17. The pattern of ganglioside distribution in Lewis rat
liver is already classified as a-type, which is character-
ized by dominance of a-series gangliosides16. In Wistar
Furth pancreas, the main ganglioside fractions are GM3,
GD3, GD1a, GT1b and a trisialoganglioside migrating
above the GT1b standard (42.7, 7, 20.2, 13.8, and 6.8, re-
spectively)17. Since GM3 and GD1a gangliosides are known
to modulate the activity of epidermal growth factor re-
ceptor9,10 and the insulin receptor7, our results will be
discussed from this point of view. Liver weight/body
weight ratio was significantly higher in Wistar compared
to other two strains and only Wistar rats showed consid-
erable amount of GM3 ganglioside in the liver. GM3
ganglioside was primarily described as inhibitor of EGF
receptor autophosphorylation9. On the contrary, recent
investigations with untransformed human fibroblasts,
which lacked GM3, and complex gangliosides show that
EGF signal transduction is reduced in the absence of
GM318. Our results of reduced GM3 content and reduced
liver weight/body weight in Lewis and SD rats are consis-
tent with a number of previous studies that have sug-
gested a positive effect of GM3 on cell function. Examples
include restoration by GM3 on fibroblast morphology dis-
torted by inhibition of glycolipid synthesis19 and suppres-
sion of metastasis by silencing of GM3 synthase in a tu-
mor model20. Pancreas weight/body weight ratio was
significantly higher in SD compared to other two strains
(p<0.05) and pancreatic b-series gangliosides (GD1b and
GT1b) were several folds lower expressed in SD com-
pared to Wistar and Lewis rats. After birth, introduction
of nutrients into the digestive tract add exogenous fac-
tors to the regulation of pancreatic development. Special
sensory and gastrointestinal afferent neural signals, along
with blood-borne metabolic signals, impinge on parallel
central autonomic circuits located in the brainstem and
hypothalamus to signal changes in metabolic balance21.
Taking into account that Wistar and SD rats differ con-
siderably in their mitochondrial respiration, our findings
of different hepatic and pancreatic weight/body weight
ratios and ganglioside expression are not surprising22.
The stimulation index of SD pancreatic islets after glu-
cose challenge, (measured on the samples of 20 islets) is
the lowest in SD islets compared to that of Wistar and
Lewis islets3. Reciprocal relation of hepatic and pancre-
atic weight/body weight ratios in Wistar and SD rats is
intriguing because those rat strains differed statistically
significantly in weight ratios of both organs in our exper-
iment. In conclusion, our study revealed differences in
the hepatic and pancreatic ganglioside phenotypes be-
tween Wistar, Lewis and SD rats that could influence
growth factor secretion and action.
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GLIKOSFINGOLIPIDNI FENOTIP JETRE I GU[TERA^E TRIJU NEUROLO[KI RAZLI^ITIH
[TAKORSKIH SOJEVA
S A @ E T A K
Tri ~esto upotrebljavana soja laboratorijskih {takora, Wistar, Lewis, Sprague-Dawley (SD), pokazuju razli~ite neu-
rolo{ke karakteristike. Jetra je glavno mjesto sinteze inzulinu sli~nog ~imbenika rasta (insulin like growth factor, IGF)
dok je gu{tera~a mjesto sinteze inzulina. Inzulin poti~e neuralni razvoj a utjecaj IGF-I klju~an je kod rasta mozga.
Glikosfingolipidi (GSL) su va`ni posrednici u izlu~ivanju i djelovanju inzulina. U ovoj studiji istra`ivan je GSL fenotip
jetre i gu{tera~e s pretostavkom da se razlikuje izme|u tri {takorska soja. Ukupne GSL frakcije (neutralni i gangliozidi)
analizirani su tankoslojnom kromatografijom visokog razlu~ivanja (high performance thin layer chromatography, HPTLC).
Slo`eni gangliozidi detektirani su imunobojenjem HPTLC plo~a B podjedinicom toksina kolere nakon tretiranja neura-
minidazom. [takori Wistar su imali najve}i omjer mase jetre i mase tijela a {takori SD najve}i omjer mase gu{tera~e i
mase tijela. Kod {takora SD prona|ena je oskudna koli~ina GD1a i gangliozida b-serije u jetri. B-serija gangliozida
tako|er je bila niska u gu{tera~i SD {takora. Ova studija predstavlja razlike u fenotipu jetrenih i gu{tera~inih ganglio-
zida triju {takorskih sojeva koje bi mogle biti odgovorne za razlike u izlu~ivanju i djelovanju IGF i inzulina.
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